NasoNeb® NDS is a division of Monaghan Medical Corporation
More Medication* to More of the Nose
Give Your Sinus and Rhinitis Patients the Benefits of Superior Depth of Spray Penetration
Use with prescribed intranasal medications*, nasal-safe OTC decongestant sprays, saline, nasal moisturizers and nasal rinse solutions.
Superior intranasal medication* delivery with the NasoNeb® Sinus Therapy System
Pharmacists trust the evidence-backed NasoNeb® Sinus Therapy System to:
Deliver 98% more medication to the middle and posterior regions of the nose than rinse bottles1,
Deposits a high concentration of intranasal medication* to nasal and sinus tissue - not the lungs.
Encourage patient adherence; a mess-free treatment takes under 1 minute
Readily available at
and other major distributors
Great profit margins with NasoNeb® Products.
Grow your pharmacy's
Lifetime Customer Value
with NasoNeb® Products.
Keep customers returning to your pharmacy between flare-ups for NasoNeb® accessories and solutions, and other compatible products in your Cough and Cold aisle.
Intranasal Medications
Medications* to treat upper respiratory pathologies are prescribed by physicians and nurse practitioners for intranasal delivery.
OTC Nasal Solutions
Over-the-counter offerings such as nasal moisturizers, prepared saline, saline packets, intranasal decongestants, and nasal rinse mixes are additional products that can be used in the system to irrigate, and combat nasal congestion and dryness.
Trusted by ENT Doctors
Superior deposition in the middle and posterior regions of the nose
“Treating chronic sinus disease revolves around optimal delivery of topical medications to inflamed and infected tissue. The NasoNeb® system does this much more effectively than simple sprays.”
Dr. Rodney Schlosser MD
Professor and Director of Rhinology and Sinus Surgery in the Department of Otolaryngology at the Medical University of South CarolinaMedical Advisor for NasoNeb®
"Delivery of corticosteroids, antibiotics and other medications to the middle and posterior regions in the nose is critical in improved outcomes for pre and post-operative patients. I was struck by the evidence that the NasoNeb® system delivers up to 51% more medication in the middle and 100% more in the posterior region. Rinse bottles and spray pumps inability to reach the external portion of the middle turbinate wherein lies the sinus, is a real problem as the whole impetus for nasal irrigation is built on the requirement to affect this area of the nasal cavity."
Dr. Brian Rotenberg MD MPH FRCSC
Professor, Otolaryngology - Head and Neck SurgerySchulich School of Medicine and DentistryWestern University
All NasoNeb® Products are FSA and HSA eligible so you can use your Flexible Spending & Health Savings Accounts.
It's time to add NasoNeb® products to your pharmacy shelf
Learn More
Need more information? Submit the form or email us at hcp@nasoneb.com with your questions.
Add to your Pharmacy Shelf
Improve outcomes and increase store profitability by submitting a reseller application today.
All NasoNeb® Products are FSA and HSA eligible so you can use your Flexible Spending & Health Savings Accounts.
Become a NasoNeb® Product Reseller
It's time to add NasoNeb® products to your pharmacy shelf
Learn More
Need more information? Submit the form below or email us at hcp@nasoneb.com with your questions.
Add to your Pharmacy Shelf
Improve outcomes and increase store profitability by submitting a reseller application today.
The NasoNeb® NDS Division, Monaghan Medical respects your privacy. All information submitted is for the sole purpose of assessing your application and will be kept confidential. We will not provide your information to another party.
*Medicinal substances to treat nasal disorders in accordance with their FDA labels or as prescribed by a healthcare professional.
¹ Nagel, M., and B. W. Rotenberg. "Comparison of Budesonide Delivery Via Nasal Spray and a Nasal Nebulizer to an In Vitro Adult Model." TP6. TP006 CLINICAL STUDIES OF ALLERGIC AIRWAY DISEASES, LUPUS, AND EOSINOPHILIC DISEASES. American Thoracic Society, 2021. A1338-A1338. Presented at ARS 2021 Los Angeles. A021.)